Nonopioid drugs coverage required for treatment or management of pain.

HF 1807 requires health insurance plans in Minnesota to treat nonopioid drugs approved by the FDA for pain treatment equally with opioids in their coverage. Specifically, it prohibits insurers from designating nonopioid pain drugs as "nonpreferred" when opioids are preferred or imposing stricter requirements (like prior authorization) on nonopioid drugs than on opioids. This applies immediately upon FDA approval of a nonopioid drug for pain management. The bill directly affects health insurance plans managing drug formularies and ensures patients seeking pain treatment have equal access to nonopioid options without unnecessary barriers.